Watts Ryan J.
SEC CIK 1724310 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| DNLI | Denali Therapeutics Inc. | Pres, CEO, Dir | 2.12M | — | $21.90M | 43 | 2021-07-01 | 2026-08-12 |
Most active insiders at DNLI, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Watts Ryan J. | Pres, CEO, Dir | — | $580.8K |
| 2 | Schuth Alexander O. | COFO, Sec | — | $420.6K |
| 3 | Thornberry Nancy | Dir | — | $261.9K |
| 4 | Chin Peter Scott | Chief Medical Off | — | $36.9K |
| 5 | Van Hauwermeiren Timothy | Dir | — | — |
| 6 | Cook Jennifer E. | Dir | — | — |
| 7 | Krognes Steve E. | Dir | — | — |
| 8 | Schenkein David P | Dir | — | — |
| 9 | Klein Peter S | Dir | — | — |
| 10 | BAKER BROS. ADVISORS LP | Dir | — | — |
Transactions 43
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2026-08-14 16:48 | 2026-08-12 | DNLI | Denali Therapeutics Inc. | Watts Ryan J. | Pres, CEO, Dir | G - Gift | $0.00 | -32.2K | 2.12M | -1% | $0 |
| 2026-01-08 | 2026-01-06 | DNLI | Denali Therapeutics Inc. | Watts Ryan J. | Pres, CEO, Dir | S - Sale | $16.50 | -35.2K | 296.8K | -11% | -$580.8K | |
| D | 2026-01-05 | 2026-01-03 | DNLI | Denali Therapeutics Inc. | Watts Ryan J. | Pres, CEO, Dir | A - Grant | $0.00 | +79.0K | 332.0K | +31% | $0 |
| I | 2025-09-05 | 2025-09-03 | DNLI | Denali Therapeutics Inc. | Watts Ryan J. | Pres, CEO, Dir | G - Gift | $0.00 | -50.0K | 2.15M | -2% | $0 |
| DM | 2025-07-11 | 2025-07-09 | DNLI | Denali Therapeutics Inc. | Watts Ryan J. | Pres, CEO, Dir | M - OptEx | $1.05 | +495.3K | 708.4K | +232% | +$520.8K |
| D | 2025-07-11 | 2025-07-09 | DNLI | Denali Therapeutics Inc. | Watts Ryan J. | Pres, CEO, Dir | S - Sale+OE | $15.00 | -495.3K | 253.1K | -66% | -$7.43M |
| M | 2025-01-08 | 2025-01-06+ | DNLI | Denali Therapeutics Inc. | Watts Ryan J. | Pres, CEO, Dir | S - Sale | $20.34 | -36.9K | 253.1K | -13% | -$751.0K |
| D | 2025-01-07 | 2025-01-03 | DNLI | Denali Therapeutics Inc. | Watts Ryan J. | Pres, CEO, Dir | A - Grant | $0.00 | +54.2K | 290.0K | +23% | $0 |
| D | 2024-10-22 | 2024-10-18 | DNLI | Denali Therapeutics Inc. | Watts Ryan J. | Pres, CEO, Dir | M - OptEx | $0.68 | +40.0K | 275.8K | +17% | +$27.2K |
| D | 2024-10-22 | 2024-10-18 | DNLI | Denali Therapeutics Inc. | Watts Ryan J. | Pres, CEO, Dir | S - Sale+OE | $27.69 | -40.0K | 235.8K | -15% | -$1.11M |
| 2024-08-22 | 2024-08-20 | DNLI | Denali Therapeutics Inc. | Watts Ryan J. | Pres, CEO, Dir | S - Sale | $23.79 | -2,260 | 235.8K | -0.9% | -$53.8K | |
| I | 2024-03-29 | 2024-03-29 | DNLI | Denali Therapeutics Inc. | Watts Ryan J. | Pres, CEO, Dir | G - Gift | $0.00 | -40.0K | 2.20M | -2% | $0 |
| 2024-02-15 | 2024-02-13 | DNLI | Denali Therapeutics Inc. | Watts Ryan J. | Pres, CEO, Dir | S - Sale | $17.29 | -9,589 | 238.1K | -4% | -$165.8K | |
| I | 2024-01-11 | 2024-01-09 | DNLI | Denali Therapeutics Inc. | Watts Ryan J. | Pres, CEO, Dir | S - Sale | $19.78 | -7,818 | 2.27M | -0.3% | -$154.6K |
| I | 2024-01-09 | 2024-01-05 | DNLI | Denali Therapeutics Inc. | Watts Ryan J. | Pres, CEO, Dir | S - Sale | $19.43 | -17.5K | 2.28M | -0.8% | -$339.7K |
| D | 2024-01-05 | 2024-01-03 | DNLI | Denali Therapeutics Inc. | Watts Ryan J. | Pres, CEO, Dir | A - Grant | $0.00 | +89.5K | 273.0K | +49% | $0 |
| I | 2023-08-23 | 2023-08-21 | DNLI | Denali Therapeutics Inc. | Watts Ryan J. | Pres, CEO, Dir | S - Sale | $22.59 | -2,309 | 2.24M | -0.1% | -$52.2K |
| DI | 2023-08-14 | 2023-08-10 | DNLI | Denali Therapeutics Inc. | Watts Ryan J. | Pres, CEO, Dir | M - OptEx | $0.68 | +2,526 | 2.24M | +0.1% | +$1,718 |
| DI | 2023-08-14 | 2023-08-10 | DNLI | Denali Therapeutics Inc. | Watts Ryan J. | Pres, CEO, Dir | S - Sale+OE | $25.03 | -2,526 | 2.24M | -0.1% | -$63.2K |
| DI | 2023-06-20 | 2023-06-16 | DNLI | Denali Therapeutics Inc. | Watts Ryan J. | Pres, CEO, Dir | M - OptEx | $0.68 | +50.0K | 2.29M | +2% | +$34.0K |
| DI | 2023-06-20 | 2023-06-16 | DNLI | Denali Therapeutics Inc. | Watts Ryan J. | Pres, CEO, Dir | S - Sale+OE | $31.40 | -50.0K | 2.24M | -2% | -$1.57M |
| DMI | 2023-04-24 | 2023-04-20+ | DNLI | Denali Therapeutics Inc. | Watts Ryan J. | Pres, CEO, Dir | M - OptEx | $0.68 | +25.0K | 2.24M | +1% | +$17.0K |
| DMI | 2023-04-24 | 2023-04-20+ | DNLI | Denali Therapeutics Inc. | Watts Ryan J. | Pres, CEO, Dir | S - Sale+OE | $25.15 | -25.0K | 2.24M | -1% | -$628.7K |
| DI | 2023-02-15 | 2023-02-13 | DNLI | Denali Therapeutics Inc. | Watts Ryan J. | Pres, CEO, Dir | M - OptEx | $0.68 | +25.0K | 2.26M | +1% | +$17.0K |
| DMI | 2023-02-15 | 2023-02-13 | DNLI | Denali Therapeutics Inc. | Watts Ryan J. | Pres, CEO, Dir | S - Sale+OE | $30.08 | -33.8K | 2.24M | -1% | -$1.02M |
| DMI | 2023-02-13 | 2023-02-09+ | DNLI | Denali Therapeutics Inc. | Watts Ryan J. | Pres, CEO, Dir | S - Sale+OE | $29.28 | -28.4K | 2.23M | -1% | -$832.5K |
| DI | 2023-02-13 | 2023-02-10 | DNLI | Denali Therapeutics Inc. | Watts Ryan J. | Pres, CEO, Dir | M - OptEx | $0.68 | +25.0K | 2.25M | +1% | +$17.0K |
| I | 2023-01-09 | 2023-01-05 | DNLI | Denali Therapeutics Inc. | Watts Ryan J. | Pres, CEO, Dir | S - Sale | $28.44 | -4,800 | 2.22M | -0.2% | -$136.5K |
| DI | 2023-01-05 | 2023-01-04 | DNLI | Denali Therapeutics Inc. | Watts Ryan J. | Pres, CEO, Dir | S - Sale | $28.73 | -5,029 | 2.21M | -0.2% | -$144.5K |
| D | 2023-01-05 | 2023-01-03 | DNLI | Denali Therapeutics Inc. | Watts Ryan J. | Pres, CEO, Dir | A - Grant | $0.00 | +82.2K | 231.9K | +55% | $0 |
| I | 2022-08-23 | 2022-08-19 | DNLI | Denali Therapeutics Inc. | Watts Ryan J. | Pres, CEO, Dir | S - Sale | $33.22 | -2,404 | 2.20M | -0.1% | -$79.9K |
| I | 2022-02-15 | 2022-02-11 | DNLI | Denali Therapeutics Inc. | Watts Ryan J. | Pres, CEO, Dir | S - Sale | $34.72 | -9,491 | 2.13M | -0.4% | -$329.5K |
| DI | 2022-02-11 | 2022-02-09 | DNLI | Denali Therapeutics Inc. | Watts Ryan J. | Pres, CEO, Dir | S - Sale+OE | $37.55 | -2,719 | 2.12M | -0.1% | -$102.1K |
| DM | 2022-02-11 | 2022-02-10 | DNLI | Denali Therapeutics Inc. | Watts Ryan J. | Pres, CEO, Dir | M - OptEx | $5.65 | +70.7K | 254.5K | +38% | +$400.0K |
| I | 2022-01-07 | 2022-01-05 | DNLI | Denali Therapeutics Inc. | Watts Ryan J. | Pres, CEO, Dir | S - Sale | $44.78 | -5,007 | 2.11M | -0.2% | -$224.2K |
| D | 2022-01-05 | 2022-01-03 | DNLI | Denali Therapeutics Inc. | Watts Ryan J. | Pres, CEO, Dir | A - Grant | $0.00 | +62.0K | 213.7K | +41% | $0 |
| MI | 2021-12-03 | 2021-12-01 | DNLI | Denali Therapeutics Inc. | Watts Ryan J. | Pres, CEO, Dir | S - Sale | $44.92 | -18.3K | 2.10M | -0.9% | -$823.6K |
| MI | 2021-11-03 | 2021-11-01 | DNLI | Denali Therapeutics Inc. | Watts Ryan J. | Pres, CEO, Dir | S - Sale | $49.76 | -18.3K | 2.14M | -0.9% | -$912.2K |
| MI | 2021-10-05 | 2021-10-01 | DNLI | Denali Therapeutics Inc. | Watts Ryan J. | Pres, CEO, Dir | S - Sale | $50.38 | -18.3K | 2.14M | -0.8% | -$923.6K |
| MI | 2021-09-03 | 2021-09-01 | DNLI | Denali Therapeutics Inc. | Watts Ryan J. | Pres, CEO, Dir | S - Sale | $54.66 | -18.3K | 2.17M | -0.8% | -$1.00M |
| MI | 2021-08-23 | 2021-08-19 | DNLI | Denali Therapeutics Inc. | Watts Ryan J. | Pres, CEO, Dir | S - Sale | $49.57 | -2,376 | 2.18M | -0.1% | -$117.8K |
| MI | 2021-08-04 | 2021-08-02 | DNLI | Denali Therapeutics Inc. | Watts Ryan J. | Pres, CEO, Dir | S - Sale | $51.41 | -18.3K | 2.18M | -0.8% | -$942.5K |
| MI | 2021-07-06 | 2021-07-01 | DNLI | Denali Therapeutics Inc. | Watts Ryan J. | Pres, CEO, Dir | S - Sale | $77.26 | -18.3K | 2.21M | -0.8% | -$1.42M |
Purchase Sale Sale after option exercise All abbreviations